Taking these cancer-preventive measures into account, we assessed the cumulative risk of first onset of pre/neoplasia (cancer and polyps combined) by age in carriers of the MSH6 variant alone over non-carriers of either MMR variant and did observe a significantly increased risk. This evidence concerns the gene MSH6 and neoplasm.